Received: 15 December 2017
Accepted: 17 April 2018
First Online: 9 May 2018
Ethics approval and consent to participate
: This study was reviewed and approved by the Health Research Ethics Board of Alberta – Cancer Committee (HREBA.CC-16-0646).
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.